These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 1909909

  • 1. [Presence of specific mutation of Ha-ras oncogene in skin tumors of mice induced under different experimental conditions].
    Loktionov AS, Popovich IG, Zabezhinskiĭ MA, Anisimov VN.
    Biull Eksp Biol Med; 1991 Apr; 111(4):398-400. PubMed ID: 1909909
    [Abstract] [Full Text] [Related]

  • 2. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
    Owens DM, Spalding JW, Tennant RW, Smart RC.
    Cancer Res; 1995 Jul 15; 55(14):3171-8. PubMed ID: 7606738
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
    Wang XJ, Liefer KM, Greenhalgh DA, Roop DR.
    Mol Carcinog; 1999 Dec 15; 26(4):305-11. PubMed ID: 10569807
    [Abstract] [Full Text] [Related]

  • 10. Epidermal papillomas and carcinomas induced in uninitiated mouse skin by tumor promoters alone contain a point mutation in the 61st codon of the Ha-ras oncogene.
    Pelling JC, Neades R, Strawhecker J.
    Carcinogenesis; 1988 Apr 15; 9(4):665-7. PubMed ID: 3128410
    [Abstract] [Full Text] [Related]

  • 11. [Activation of the Ha-ras oncogene in tumors induced in mice by transplacental exposure to 7,12-dimethylbenz(a)anthracene].
    Loktionov AS, Hollstein M, Martel N, Galendo D, Tomatis L, Yamasaki H.
    Vopr Onkol; 1991 Apr 15; 37(3):297-303. PubMed ID: 1903226
    [Abstract] [Full Text] [Related]

  • 12. Metallothionein deficiency enhances skin carcinogenesis induced by 7,12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate in metallothionein-null mice.
    Suzuki JS, Nishimura N, Zhang B, Nakatsuru Y, Kobayashi S, Satoh M, Tohyama C.
    Carcinogenesis; 2003 Jun 15; 24(6):1123-32. PubMed ID: 12807749
    [Abstract] [Full Text] [Related]

  • 13. Dietary fat effects on the initiation and promotion of two-stage skin tumorigenesis in the SENCAR mouse.
    Birt DF, White LT, Choi B, Pelling JC.
    Cancer Res; 1989 Aug 01; 49(15):4170-4. PubMed ID: 2472874
    [Abstract] [Full Text] [Related]

  • 14. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
    Ewing MW, Conti CJ, Kruszewski FH, Slaga TJ, DiGiovanni J.
    Cancer Res; 1988 Dec 15; 48(24 Pt 1):7048-54. PubMed ID: 3142681
    [Abstract] [Full Text] [Related]

  • 15. Transplacental induction of a specific mutation in fetal Ha-ras and its critical role in post-natal carcinogenesis.
    Yamasaki H, Hollstein M, Martel N, Cabral JR, Galendo D, Tomatis L.
    Int J Cancer; 1987 Dec 15; 40(6):818-22. PubMed ID: 2891626
    [Abstract] [Full Text] [Related]

  • 16. Skin tumorigenesis and Ki-ras and Ha-ras mutations in tumors from adult mice exposed in utero to 3'-azido-2',3'-dideoxythymidine.
    Zhang Z, Diwan BA, Anderson LM, Logsdon D, Olivero OA, Haines DC, Rice JM, Yuspa SH, Poirier MC.
    Mol Carcinog; 1998 Sep 15; 23(1):45-51. PubMed ID: 9766437
    [Abstract] [Full Text] [Related]

  • 17. Transgenic coexpression of v-Ha-ras and transforming growth factor alpha increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous c-Ha-ras activation.
    Wang XJ, Greenhalgh DA, Roop DR.
    Mol Carcinog; 2000 Mar 15; 27(3):200-9. PubMed ID: 10708482
    [Abstract] [Full Text] [Related]

  • 18. Non-melanoma skin cancer in mouse and man.
    Schwarz M, Münzel PA, Braeuning A.
    Arch Toxicol; 2013 May 15; 87(5):783-98. PubMed ID: 23266722
    [Abstract] [Full Text] [Related]

  • 19. Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis.
    Philipp J, Vo K, Gurley KE, Seidel K, Kemp CJ.
    Oncogene; 1999 Aug 19; 18(33):4689-98. PubMed ID: 10467416
    [Abstract] [Full Text] [Related]

  • 20. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
    Iversen OH.
    APMIS Suppl; 1994 Aug 19; 41():1-38. PubMed ID: 7946481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.